DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

申请号：

IL22350212

公开号：

IL223502D0

申请日:

2012.12.06

申请国别(地区):

IL

年份:

2013

代理人:

摘要：

S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being the accumulation factor) standard daily dosage is administered and thereafter continued at the standard daily dosage or at a daily dosage lower than the standard daily dosage.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/